AHA 2021: Late-breaking Science Video Collection
Published: 12 November 2021
AHA 2021: Evaluating the Benefit of Concomitant TV Repair During Mitral Valve Surgery
- Population Strategies for the Management of Hypertension
- ROSE: CETPi Lowers LDL-C in Patients Taking High Intensity Statins
- AXIOMATIC-TKR: Patients Treated with Milvexian Show Reduced Rate of Venous Thromboembolism
- EAST-AFNET 4: Early Rhythm Control Was Consistent in AF Patterns
- EMPEROR-Preserved: Empagliflozin, Health Status, & QoL in Patients With HFp
- AHA 2021: Evaluating the Benefit of Concomitant TV Repair During Mitral Valve Surgery
- SGLT2 is Associated with Reduction in Atrial-Arrythmic Events
- SMART-CRT: Effects of AV Optimization on CRT Outcomes
- AVATAR: Aortic Valve Replacement Vs Watchful Waiting in Asymptomatic Severe AS
- EMPATROPISM FE: Effects of Empagliflozin on iron metabolism in non-diabetic HF patients
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen provide a concise and insightful preview of the late-breaking science presented at AHA Scientific Sessions 2021.
For a deep-dive, watch Dr Harriette Van Spall's Late-breaking Discussion series on highly expected trials with principal investigators.
Short, accessible Expert Interviews will be available conducted with select faculty focusing on the results, applicability, and impact on future research.